CH475997A - Verfahren zur Herstellung einer antibiotisch wirksamen Substanz - Google Patents

Verfahren zur Herstellung einer antibiotisch wirksamen Substanz

Info

Publication number
CH475997A
CH475997A CH1683365A CH1683365A CH475997A CH 475997 A CH475997 A CH 475997A CH 1683365 A CH1683365 A CH 1683365A CH 1683365 A CH1683365 A CH 1683365A CH 475997 A CH475997 A CH 475997A
Authority
CH
Switzerland
Prior art keywords
production
antibiotic substance
antibiotic
substance
Prior art date
Application number
CH1683365A
Other languages
English (en)
Inventor
Willy Dr Leimgruber
Vladimir Dr Stefanovic
Original Assignee
Danbal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbal Ag filed Critical Danbal Ag
Publication of CH475997A publication Critical patent/CH475997A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
CH1683365A 1964-12-07 1965-12-07 Verfahren zur Herstellung einer antibiotisch wirksamen Substanz CH475997A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US416599A US3361742A (en) 1964-12-07 1964-12-07 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides

Publications (1)

Publication Number Publication Date
CH475997A true CH475997A (de) 1969-07-31

Family

ID=23650586

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1683365A CH475997A (de) 1964-12-07 1965-12-07 Verfahren zur Herstellung einer antibiotisch wirksamen Substanz

Country Status (11)

Country Link
US (1) US3361742A (de)
AT (1) AT269350B (de)
BE (1) BE673376A (de)
BR (1) BR6575537D0 (de)
CH (1) CH475997A (de)
DE (1) DE1467872A1 (de)
ES (1) ES320436A1 (de)
FR (1) FR1553664A (de)
GB (1) GB1092888A (de)
NL (1) NL6515880A (de)
SE (1) SE316136B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3523941A (en) * 1967-03-06 1970-08-11 Hoffmann La Roche Benzodiazepine compounds and process for their preparation
US3524849A (en) * 1967-10-27 1970-08-18 Hoffmann La Roche Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein
DE1965304A1 (de) * 1968-12-30 1970-07-23 Fujisawa Pharmaceutical Co Benzdiazepinon-Verbindungen und Verfahren zu ihrer Herstellung
JPS5279082A (en) * 1975-12-25 1977-07-02 Green Cross Corp:The Preparation of anti-tumor compound
JPS585916B2 (ja) 1977-12-27 1983-02-02 株式会社ミドリ十字 新規ベンゾジアゼピン系化合物
CA1214774A (en) * 1983-02-10 1986-12-02 Yusei Shiraga Benzodiazepine derivative
AUPO470197A0 (en) * 1997-01-21 1997-02-13 Attfield, Paul Victor Fluorescent dyes from microorganisms
MX368648B (es) 2010-04-15 2019-10-09 Seattle Genetics Inc Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
CN103068405A (zh) 2010-04-15 2013-04-24 西雅图基因公司 靶向吡咯并苯并二氮杂卓结合物
US9399641B2 (en) 2011-09-20 2016-07-26 Medimmune Limited Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates
CA2850264C (en) 2011-10-14 2019-11-05 Medimmune Limited Pyrrolobenzodiazepines
CA2850373C (en) 2011-10-14 2019-07-16 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
AU2012322934B2 (en) 2011-10-14 2016-09-08 Medimmune Limited Pyrrolobenzodiazepines
CA2850375C (en) 2011-10-14 2019-07-02 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
PT2906248T (pt) 2012-10-12 2019-03-04 Medimmune Ltd Pirrolobenzodiazepinas e conjugados das mesmas
BR112015008238A2 (pt) 2012-10-12 2017-11-28 Adc Therapeutics Sarl conjugados de pirrolbenzodiazepina-anticorpo anti-cd22
DK2839860T3 (da) 2012-10-12 2019-06-17 Medimmune Ltd Pyrrolobenzodiazepiner og konjugater deraf
WO2014057114A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-anti-psma antibody conjugates
KR101995620B1 (ko) 2012-10-12 2019-07-03 에이디씨 테라퓨틱스 에스에이 피롤로벤조디아제핀-항체 컨주게이트
PT2906253T (pt) 2012-10-12 2018-11-05 Medimmune Ltd Conjugados de anticorpo anti-psma de pirrolobenzodiazepina
DK2906298T3 (en) 2012-10-12 2018-12-17 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
EP2906249B1 (de) 2012-10-12 2018-06-27 MedImmune Limited Synthese und zwischenprodukte pyrrolobenzodiazepinderivaten zur konjugation
EP2906297B1 (de) 2012-10-12 2017-12-06 ADC Therapeutics SA Pyrrolobenzodiazepin-antikörper-konjugate
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN107148285B (zh) 2014-11-25 2022-01-04 Adc治疗股份有限公司 吡咯并苯并二氮杂䓬-抗体缀合物
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
RS61795B1 (sr) 2017-02-08 2021-06-30 Adc Therapeutics Sa Konjugati pirolobenzodiazepin antitela
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
SMT202200490T1 (it) 2017-04-18 2023-01-13 Medimmune Ltd Coniugati di pirrolobenzodiazepina
WO2018193102A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
KR102442736B1 (ko) 2017-06-14 2022-09-16 에이디씨 테라퓨틱스 에스에이 항-cd19 adc의 투여를 위한 투약량 체제
SI3668874T1 (sl) 2017-08-18 2022-04-29 Medimmune Limited Pirolobenzodiazepinski konjugati
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN113631560B (zh) 2019-03-15 2025-02-18 麦迪穆有限责任公司 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247187A (en) * 1963-07-10 1966-04-19 Hoffmann La Roche Oxidation of 1, 4-benzodiazepines to 1, 4-benzodiazepin-2-ones

Also Published As

Publication number Publication date
US3361742A (en) 1968-01-02
DE1467872A1 (de) 1969-05-14
NL6515880A (de) 1966-06-08
BE673376A (de) 1966-04-01
AT269350B (de) 1969-03-10
FR1553664A (de) 1969-01-17
GB1092888A (en) 1967-11-29
BR6575537D0 (pt) 1973-09-06
ES320436A1 (es) 1966-05-16
SE316136B (de) 1969-10-20

Similar Documents

Publication Publication Date Title
CH490309A (de) Verfahren zur Herstellung substituierter Biphenylessigsäuren
CH478156A (de) Verfahren zur Herstellung neuartiger Antibiotika
AT275780B (de) Verfahren zur Herstellung von Sinterkörpern
CH479589A (de) Verfahren zur Herstellung von Imidazolen
CH473758A (de) Verfahren zur Herstellung von Trimethylhexamethylendiamin
CH480434A (de) Verfahren zur Herstellung des Antibiotikums Kasugamycin
AT266313B (de) Verfahren zur Herstellung einer antikoagulierend wirkenden Substanz
CH475923A (de) Verfahren zur Herstellung homöoporöser Kohlenstoffkörper
AT259762B (de) Verfahren zur Herstellung eines Antibioticums
CH454163A (de) Verfahren zur Herstellung von Polyhalogenphenolen
CH437345A (de) Verfahren zur Herstellung von cyclischen Äthern
CH454161A (de) Verfahren zur Herstellung eledoisinwirksamer Undekapeptide
AT260539B (de) Verfahren zur Herstellung von Schwefel-Harz-Massen
AT255880B (de) Verfahren zur Herstellung einer Übergußmasse
AT256808B (de) Verfahren zur Herstellung von ɛ-Caprolactam
CH461498A (de) Verfahren zur Herstellung substituierter e-Caprolactame
CH472427A (de) Verfahren zur Herstellung von Antibiotika
AT289090B (de) Verfahren zur Herstellung von Rhodanverbindungen
CH441355A (de) Verfahren zur Herstellung von Antibiotika
CH468365A (de) Verfahren zur Herstellung von Testosteron-Derivaten
AT261896B (de) Verfahren zur Herstellung von Polyvinylalkoholderivaten
AT266314B (de) Verfahren zur Herstellung des neuen Antibiotikums Lincomycin B
CH465383A (de) Verfahren zur Herstellung von Faserprodukten
CH458392A (de) Verfahren zur Herstellung von Merkaptalen
AT255614B (de) Verfahren zur Herstellung von Überzügen

Legal Events

Date Code Title Description
PL Patent ceased